TNFA

0.3931

5.98% -0.025

Dopo l'orario di chiusura: .41 0.0169 +4.30%

Tnf Pharmaceuticals Inc (TNFA)

Panoramica Notizia Cronologia dei prezzi Forum Previsione

Precedente Chiudi:

$0.4181

Aprire:

$0.41

Volume 24 ore:

969.97K

Relative Volume:

2.09

Capitalizzazione di mercato:

$1.10M

Reddito:

Utile/perdita netta:

$-23.66M

Rapporto P/E:

-0.0284

EPS:

-13.84

Flusso di cassa netto:

$-10.14M

1 W Prestazione:

-10.56%

1M Prestazione:

-46.00%

6M Prestazione:

-76.37%

1 anno Prestazione:

+0.00%

Intervallo 1D:

$0.3755

$0.4253

Intervallo di 1 settimana:

$0.3755

$0.53

Portata 52W:

$0.3755

$2.16

Tnf Pharmaceuticals Inc Stock (TNFA) Company Profile

Nome

Tnf Pharmaceuticals Inc

Settore

Healthcare (1189)

Industria

Biotechnology (682)

Telefono

856-848-8698

Indirizzo

855 N. WOLFE STREET, BALTIMORE

Dipendente

Cinguettio

Prossima data di guadagno

Ultimi documenti SEC

TNFA's Discussions on Twitter

Confronta TNFA con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
TNFA Tnf Pharmaceuticals Inc	0.3931	1.10M	0	-23.66M	-10.14M	-13.84
VRTX Vertex Pharmaceuticals Inc	483.31	124.35B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	684.87	75.07B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	622.61	37.96B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	243.53	31.79B	2.25B	-278.16M	-42.59M	-2.17
BNTX Biontech Se Adr	111.56	27.34B	3.30B	-501.07M	1.03B	-2.1146

Tnf Pharmaceuticals Inc Borsa (TNFA) Ultime notizie

12:58 PM

RILY’s current quarter earnings: What analysts forecast? - US Post News

12:58 PM

04:14 AM

LGVN To Complete ELPIS II Enrollment By Q2, Time To Keep An Eye On NXGL, What's The Buzz At ACON? - RTTNews

04:14 AM

Feb 26, 2025

Are T1 Energy Inc (FREY) shares a good deal now? - US Post News

Feb 26, 2025

TNF Pharmaceuticals Initiates Phase 2b Clinical Trial of First Oral TNF-Alpha Inhibitor - BioSpace

Feb 26, 2025

Feb 25, 2025

Can This First-Ever Oral TNF Inhibitor Disrupt a $40 Billion Market? Phase 2b Trial Begins - StockTitan

Feb 25, 2025

Feb 24, 2025

TNFA stock touches 52-week low at $0.43 amid market challenges - Investing.com Australia

Feb 24, 2025

Feb 21, 2025

Sarcopenia Market Share Projected to Climb to USD 4.23 Billion by 2030 - Industry Today

Feb 21, 2025

Feb 16, 2025

TNFA stock touches 52-week low at $0.48 amid market challenges - MSN

Feb 16, 2025

Feb 14, 2025

TNFA stock touches 52-week low at $0.48 amid market challenges By Investing.com - Investing.com South Africa

Feb 14, 2025

Feb 11, 2025

Teva- Pharmaceutical Industries Ltd. ADR’s: Contrasting Stock Performances in a Volatile Market - The InvestChronicle

Feb 11, 2025

FHN’s Stock Market Expedition: Traversing Gains and Losses in 2023 - The InvestChronicle

Feb 11, 2025

Feb 10, 2025

Bio-Thera Solutions Announces Exclusive Commercialization and License Agreement with Intas Pharmaceuticals for BAT2506, a Proposed Biosimilar Referencing Simponi® (golimumab), in the United States of America - BioSpace

Feb 10, 2025

Feb 07, 2025

12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga

Feb 07, 2025

Post-Trade Analysis: Avinger Inc (AVGR) Slides -30.15, Closing at 0.39 - The Dwinnex

Feb 07, 2025

Daily Market Movement: Lottery.com Inc (LTRY) Sees a 187.81 Increase, Closing at 1.41 - The Dwinnex

Feb 07, 2025

In the Green: TNF Pharmaceuticals Inc (TNFA) Closes at 0.60, Up/Down 6.96 from Previous Day - The Dwinnex

Feb 07, 2025

Jan 30, 2025

TNFA stock touches 52-week low at $1.02 amid market challenges - MSN

Jan 30, 2025

Jan 29, 2025

TNFA stock touches 52-week low at $1.02 amid market challenges By Investing.com - Investing.com South Africa

Jan 29, 2025

TNF Pharmaceuticals to study TNF-alpha in patients taking GLP-1s - TipRanks

Jan 29, 2025

TNF Pharmaceuticals Launches Study Series Aimed at Preserving Lean Muscle Mass During GLP-1 Weight Loss Treatment - Marketscreener.com

Jan 29, 2025

Revolutionary Drug Could Solve the Hidden Problem with Ozempic and Wegovy Weight Loss - StockTitan

Jan 29, 2025

Jan 23, 2025

12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga

Jan 23, 2025

Jan 21, 2025

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga

Jan 21, 2025

InMed's Alzheimer's Drug Shows Breakthrough Results in Reducing Brain Inflammation - StockTitan

Jan 21, 2025

Jan 17, 2025

Coeptis Therapeutics (Nasdaq: COEP) Emerges as a Biopharma Innovator Leveraging AI-Driven Marketing - The Globe and Mail

Jan 17, 2025

Jan 15, 2025

TNF Pharmaceuticals to expand clinical trials for isomyosamine - Investing.com

Jan 15, 2025

TNF Pharmaceuticals Announces Positive Clinical Data Supporting Clinical Trial Expansion - Business Wire

Jan 15, 2025

Jan 06, 2025

Shattuck Labs CEO to Present at J.P. Morgan Healthcare Conference 2025 - StockTitan

Jan 06, 2025

Dec 19, 2024

TNF Pharmaceuticals Announces Trial to Explore Effects of Lead Candidate in Sarcopenia/Frailty Induced by GLP-1 Weight Loss Drugs - Business Wire

Dec 19, 2024

Dec 13, 2024

PharmaCyte Biotech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2024 - Marketscreener.com

Dec 13, 2024

Inflammatory Bowel Disease Treatment Market Report 2024, Share And Growth - WhaTech

Dec 13, 2024

Dec 11, 2024

TNF Alpha Inhibitors Market Overview 2024-2033 – Share, Trends, Demand, Outlook - WhaTech

Dec 11, 2024

Dec 10, 2024

Premarket Action Is Heating Up For This Biotech - MSN

Dec 10, 2024

PHLX Japanese Yen (XDN) QuotePress Release - The Globe and Mail

Dec 10, 2024

TSX Consumer Staples Capped Index (TTCS) QuotePress Release - The Globe and Mail

Dec 10, 2024

TSX Venture Composite Index (JX) QuotePress Release - The Globe and Mail

Dec 10, 2024